Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria

• Seema T. Meloni,

  Affiliation Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Charlotte A. Chang,

  Affiliation Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Geoffrey Eisen,

  Affiliation Center for Global Health, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Toyin Jolayemi,

  Affiliation AIDS Prevention Initiative in Nigeria, Limited by Guarantee, Abuja, Federal Capital Territory, Nigeria

  ⨯
• Bolanle Banigbe,

  Affiliation AIDS Prevention Initiative in Nigeria, Limited by Guarantee, Abuja, Federal Capital Territory, Nigeria

  ⨯
• Prosper I. Okonkwo,

  Affiliation AIDS Prevention Initiative in Nigeria, Limited by Guarantee, Abuja, Federal Capital Territory, Nigeria

  ⨯
• Phyllis J. Kanki

  * E-mail: pkanki@hsph.harvard.edu

  Affiliation Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  ⨯